Medical Properties Trust
Valuation each multiple against its own 5-year range
Vs. peers REIT - Healthcare Facilities
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Medical Properties Trust (MPT) | 1.03B | 4.17 | 0.22 | 20.57% |
| Welltower (WELL) | 176.32B | 104.95 | 3.63 | 1.28% |
| American Healthcare REIT (AHR) | 13.35B | 117.43 | 2.41 | 1.74% |
| Healthpeak Properties (DOC) | 13.27B | 35.63 | 1.69 | 6.34% |
| National Healthcare Properties (NHP) | 1.08B | -45.18 | 1.18 | 0.51% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 48.5% below Morningstar's fair value estimate.
Fair value
Medical Properties Trust Inc earns a 5-star quantitative star rating, indicating our belief that this share class offers a compelling opportunity for investors. The stock currently trades at a 36% discount to our quantitative fair value estimate of $2.60 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The company's profitability bolsters our estimated valuation. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. Reflecting the firm's profitability is its sales yield of 95.3%, which falls in the top 40% globally. This company has a robust ability to generate sales without much capital investment, freeing up more capital to be returned to shareholders in the long run. We believe this is a sign that shares could be cheap.
The firm's valuation metrics are an additional encouraging factor. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 427.6%, for example, lies in the top 10% compared with peers globally. The market price is low relative to the book (accounting) value of the company's equity, which further promotes our favorable price/fair value ratio.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has been a laggard relative to the broader universe over the past year. This underperformance makes the stock appear cheap, which portends a buying opportunity in light of other contributors to our model.
Economic moat
With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-11-20 19:56:23 · For reference only, not investment advice and not tailored to your situation.
Medical Properties Trust discussion 0 comments